PUBLISHER: The Business Research Company | PRODUCT CODE: 1414452
PUBLISHER: The Business Research Company | PRODUCT CODE: 1414452
“Non-Invasive Ventilators Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on non-invasive ventilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for non-invasive ventilators? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The non-invasive ventilators market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
A non-invasive ventilator serves as a medical apparatus designed to provide respiratory support to patients without requiring an invasive breathing tube. This method is commonly employed in managing respiratory conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD), and acute respiratory failure.
The primary categories of non-invasive ventilators include continuous positive airway pressure (CPAP), auto-titrating (adjustable) positive airway pressure (APAP), and bi-level positive pressure (BiPAP). CPAP delivers a consistent airway pressure maintained throughout the respiratory cycle, supporting both inhalation and exhalation. These devices utilize electric, pneumatic, and electro-pneumatic power sources and find application in treating conditions such as COPD, asthma, respiratory distress syndrome, pneumonia, among others. Non-invasive ventilation is employed across various settings including hospitals, specialized clinics, home care environments, and ambulatory surgical centers.
The non-invasive ventilators market research report is one of a series of new reports from The Business Research Company that provides non-invasive ventilators market statistics, including non-invasive ventilators industry global market size, regional shares, competitors with a non-invasive ventilators market share, detailed non-invasive ventilators market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive ventilators industry. This non-invasive ventilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The non-invasive ventilators market size has grown strongly in recent years. It will grow from $2.82 billion in 2023 to $2.99 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The expansion observed in the historical period was driven by several factors, including the development of hospital infrastructure, increased prevalence of sleep-related breathing disorders, patient inclination towards non-invasive approaches, advancements in respiratory therapy, and the aging demographic trends. The non-invasive ventilators market size is expected to see strong growth in the next few years. It will grow to $3.86 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. Anticipated growth in the forecasted period is linked to the adoption of home-based ventilation solutions, a rise in preventive healthcare measures, the implementation of pulmonary rehabilitation programs, increased awareness and educational campaigns, as well as concerns regarding climate change and air quality. Key trends expected in this period encompass the development of portable and wearable devices, the integration of smart technologies, the incorporation of remote patient monitoring and telehealth, a shift from invasive to non-invasive ventilation, and technological advancements focusing on ventilation modes.
The anticipated surge in the non-invasive ventilator market is primarily driven by the high prevalence of respiratory diseases. These conditions, including asthma and chronic lung diseases, necessitate interventions such as non-invasive ventilators to aid patients in breathing by supplying oxygen to their lungs. As highlighted by the World Health Organization in September 2022, chronic respiratory diseases contribute to 4.1 million deaths annually, marking a significant portion of the 41 million deaths attributed to chronic noncommunicable diseases (NCDs) globally. Consequently, the prevalence of respiratory ailments fuels the growth of the non-invasive ventilator market.
The escalating levels of air pollution are poised to significantly impact the growth trajectory of the non-invasive ventilator market. This pollution, characterized by harmful substances in the atmosphere, adversely affects human health and exacerbates respiratory issues. Non-invasive ventilators serve as critical aids for individuals battling respiratory problems stemming from air pollution. The World Health Organization's June 2023 report highlighted the association of air pollution, both outdoor and household, with 7 million premature deaths annually, further underlining the necessity for such ventilators. Moreover, the substantial economic impact, as emphasized by the World Bank's estimation of $8.1 trillion in health damage caused by air pollution annually, drives the market for non-invasive ventilators.
Technological advancements stand as a prominent trend fueling growth in the non-invasive ventilator market. Companies operating in this sector are adopting innovative technologies to fortify their market presence. Inspiration Healthcare Group plc's November 2023 launch of the SLE1500, a neonatal ventilator catering to delicate lungs, demonstrates this trend. This system offers multiple non-invasive delivery options in one machine, including nasal Continuous Positive Airway Pressure (nCPAP) and high-flow oxygen therapy, enhancing respiratory support for fragile infants while consolidating diverse modes of non-invasive ventilation.
Market leaders in the non-invasive ventilator domain prioritize the development of next-generation products to enhance patient care and address a wider array of respiratory conditions. Innovative ventilators, boasting advanced technologies and improved designs, aim to enhance patient comfort and efficacy. For example, Apollo Computing Laboratories (ACL) Ltd.'s July 2021 introduction of SwasthVayu, a portable non-invasive ventilator, demonstrates this focus on innovation. This compact device, highly versatile and designed for use in various medical settings, caters to COVID and non-COVID conditions, offering critical respiratory support for lung diseases, sleep apnea, and respiratory weakness in a portable and efficient manner.
In May 2021, Medline International B.V., a Netherlands-headquartered provider of medical solutions, successfully acquired specific respiratory assets from Teleflex for a sum totaling $286 million. This strategic acquisition by Medline was targeted at bolstering its standing within the global Non-Invasive Ventilation (NIV) market. Additionally, it aimed to extend its market reach across Europe and other key international territories. Teleflex Incorporated, a US-based company specializing in manufacturing a wide range of medical devices, including non-invasive ventilators utilized in various medical fields such as vascular and interventional access, surgical anesthesia, cardiac care, urology, emergency medicine, and respiratory care, was the source of these acquired respiratory assets.
Major companies operating in the non-invasive ventilators market report are ResMed Inc., Teleflex Incorporated, Hamilton Bonaduz AG, HEYER Medical AG, Airon Corporation, Fisher & Paykel Healthcare Limited, Smiths Medical International Ltd., O-Two Medical Technologies Inc., Phoenix Medical Systems Pvt. Ltd., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, General Electric Healthcare Co., Magnamed Tecnologia Medica S/A, WILAmed GmbH, Mindray Medical International Limited, Vyaire Medical Inc., GETINGE AB, Medtronic plc, Respironics Inc., medin Medical Innovations GmbH, Comen Medical Instruments Co. Ltd., Lowenstein Medical Technology GmbH + Co. KG, aXcent medical GmbH, Tenko Medical Systems Corp., Beijing Aeonmed Co. Ltd., MEKICS Co. Ltd., Sefam Medical, Becton Dickinson and Company, Allied Healthcare Products Inc., Air Liquide Medical Systems, Pulmodyne Inc., Bunnell Incorporated
North America was the largest region in the non-invasive ventilators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global non-invasive ventilator market during the forecast period. The regions covered in the non-invasive ventilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the non-invasive ventilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The non-invasive ventilator market consists of sales of high flow nasal cannula devices, non-invasive ventilation masks and non-invasive circuits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.